Prodrug and antedrug: two diametrical approaches in designing safer drugs.

RCMI Coordinating Center (RCMI CC)

Prodrug and antedrug: two diametrical approaches in designing safer drugs.

Lee HJ, Cooperwood JS, You Z, Ko DH. Prodrug and antedrug: two diametrical approaches in designing safer drugs. Arch Pharm Res. 2002 Apr; 25(2):111-36.

View in: PubMed

subject areas

Cytosine Deaminase
Drug Design
Flucytosine
Ganciclovir
Immunoconjugates
Nucleoside Deaminases
Nucleosides
Nucleotides
Prodrugs
Thymidine Kinase

authors with profiles

John S. Cooperwood

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support